Atypical Antipsychotics in the Treatment of Depressive and Psychotic Symptoms in Patients with Chronic Schizophrenia: A Naturalistic Study

Atypical Antipsychotics in the Treatment of Depressive and Psychotic Symptoms in Patients with Chronic Schizophrenia: A Naturalistic Study

Objectives. The aim of this naturalistic study was to investigate whether treatment with clozapine and other atypical antipsychotics for at least 2 years was associated with a reduction in psychotic and depressive symptoms and an improvement in chronic schizophrenia patients’ awareness of their illn...

Full description

Bibliographic Details
Main Authors:	Marco Innamorati, Stefano Baratta, Cristina Di Vittorio, David Lester, Paolo Girardi, Maurizio Pompili, Mario Amore
Format:	Article
Language:	English
Published:	Hindawi Limited 2013-01-01
Series:	Schizophrenia Research and Treatment
Online Access:	http://dx.doi.org/10.1155/2013/423205

Similar Items

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
by: Correll Christoph, et al.
Published: (2005-05-01)

Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia
by: Swartz Marvin, et al.
Published: (2006-02-01)

Atypical antipsychotics, dystonia, and psychotic depression: old solutions for new problems
by: Gazzellone, M.J, et al.
Published: (2022)

Incomplete oedipism and chronic suicidality in psychotic depression with paranoid delusions related to eyes
by: Tatarelli Roberto, et al.
Published: (2006-11-01)

Do Atypical Antipsychotics Have Antisuicidal Effects? A Hypothesis-Generating Overview
by: Maurizio Pompili, et al.
Published: (2016-10-01)

Association of typical versus atypical antipsychotics with symptoms and quality of life in schizophrenia.
by: Koichiro Fujimaki, et al.
Published: (2012-01-01)

The effects of antipsychotic drugs on depression level in patients with schizophrenia: clozapine vs. other atypical antipsychotics
by: Burkay Yakar, et al.
Published: (2016-08-01)

New atypical antipsychotics for schizophrenia: iloperidone
by: Silvio Caccia, et al.
Published: (2010-02-01)

The influence of typical and atypical antipsychotics on neurocognitive functions in patients with psychotic disorders
by: Javorac Jovan M., et al.
Published: (2019-01-01)

Partial Androgen Deficiency, Depression, and Testosterone Supplementation in Aging Men
by: Mario Amore, et al.
Published: (2012-01-01)

THE ROLE OF ATYPICAL ANTIPSYCHOTIC DECREASING AGGRESIVENESS IN SCHIZOPHRENIA
by: Juvita Novia Anggraini Maria
Published: (2013-03-01)

Atypical antipsychotics in the treatment of early-onset schizophrenia
by: Hrdlicka M, et al.
Published: (2015-04-01)

Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome
by: Sang Won Jeon, et al.
Published: (2017-10-01)

Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia
by: I. A. Vilyum, et al.
Published: (2018-08-01)

A systematic review of atypical antipsychotic drugs in schizophrenia
by: A-.M. Bagnall, et al.
Published: (2003-01-01)

Speech-on-speech masking and psychotic symptoms in schizophrenia
by: Chao Wu, et al.
Published: (2018-06-01)

EFFECT OF TYPICAL AND ATYPICAL ANTIPSYCHOTICS ON PLASMA PROLACTIN LEVELS IN SCHIZOPHRENIA
by: Muhammad Sami Bilal, et al.
Published: (2015-01-01)

Cognitive Impairment in Schizophrenia, Neurotransmitters and the New Atypical Antipsychotic Aripiprazole
by: Topolov Mariyan K., et al.
Published: (2016-03-01)

The lived experiences of people with schizophrenia prescribed atypical antipsychotic medication
by: Gill, Anthony
Published: (2013)

Lorazepam-Resistant Catatonia in an Antipsychotic-Naïve 24-Year-Old with Psychotic Symptoms
by: Juan Pablo Lucchelli, et al.
Published: (2020-01-01)

Brain Impairment in Chronic Schizophrenia Patients with Depressive Symptoms Differs from Brain Impairment in Chronic Depression Patients with Psychotic Symptoms
by: Feng Ji, et al.
Published: (2018-01-01)

Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: Data from a randomized double-blind trial
by: Zhu Young, et al.
Published: (2006-10-01)

Identification of early changes in specific symptoms that predict longer-term response to atypical antipsychotics in the treatment of patients with schizophrenia
by: Ascher-Svanum Haya, et al.
Published: (2011-02-01)

Long-acting antipsychotic drugs for the treatment of schizophrenia: use in daily practice from naturalistic observations
by: Rossi Giuseppe, et al.
Published: (2012-08-01)

Arcuate fasciculus abnormalities and their relationship with psychotic symptoms in schizophrenia.
by: Muhammad Farid Abdul-Rahman, et al.
Published: (2012-01-01)

Depression and psychotic symptoms in dementia sufferers
by: Ballard, C. G.
Published: (1995)

The Effects of Reminiscence Therapy on Psychotic Symptoms, Depression, Self-esteem and Interpersonal Interaction in Patients with Schizophrenia
by: Chiang, Gwo-Cheng, et al.
Published: (2019)

Minimizing Cardiovascular Adverse Effects of Atypical Antipsychotic Drugs in Patients with Schizophrenia
by: Fadi T. Khasawneh, et al.
Published: (2014-01-01)

Pharmacoeconomic comparison of ziprasidone with other atypical oral antipsychotic agents in schizophrenia
by: Andrea Fagiolini, et al.
Published: (2011-11-01)

Neural basis for the ability of atypical antipsychotic drugs to improve cognition in schizophrenia
by: Tomiki eSumiyoshi, et al.
Published: (2013-10-01)

Assessment of Long Term Metabolic Effects of Atypical Antipsychotics in Schizophrenia Patients
by: Cason Nicolae-Marius, et al.
Published: (2019-09-01)

A longitudinal investigation into the influence of atypical antipsychotics on cognitive function in schizophrenia
by: Tyson, Philip John
Published: (2003)

Metabolic disturbances in patients with paranoid schizophrenia treated with atypical antipsychotic drugs
by: Leonid Mikhaylovich Bardenshteyn, et al.
Published: (2010-06-01)

Atypical antipsychotics:
by: Claudia Aparecida Avelar Ferreira, et al.
Published: (2015-10-01)

Atypical antipsychotics as add-on treatment in late-life depression
by: Cakir S, et al.
Published: (2016-09-01)

Effective therapeutic dosage of antipsychotic medications in patients with psychotic symptoms: Is there a racial difference?
by: Bakare Muideen O
Published: (2008-06-01)

Predictors of antipsychotic monotherapy with olanzapine during a 1-year naturalistic study of schizophrenia patients in Japan
by: Ye W, et al.
Published: (2012-01-01)

The Correlation Between the Changes in Prolactin and Psychotic Symptoms in Patients with Schizophrenia
by: Yu-Hui Huang, et al.
Published: (2015)

Schizophrenia and psychotic symptoms in families of two American Indian tribes
by: Albaugh Bernard, et al.
Published: (2007-06-01)

Early predictors of poor treatment response in patients with schizophrenia treated with atypical antipsychotics
by: Yi-Lung Chen, et al.
Published: (2018-12-01)